Back
ESC Premium Access

Triple vs. double antithrombotic therapy in patients needing oral anticoagulation undergoing percutaneous coronary intervention: a meta-analysis

Session: Poster Session 3 - Antiplatelet therapy
Topic: Anticoagulants
Speaker: Doctor D. Errigo (Turin, IT)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Daniele Errigo

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)
0 follower

4 more presentations in this session

A randomized, pharmacodynamic comparison of low dose ticagrelor (60mg bid) to low dose prasugrel (5mg od) in patients with prior myocardial infarction: the ALTIC-2 study

Speaker: Doctor I. Lianos (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischaemic risk compared with 75-100 mg aspirin daily in coronary artery disease patients

Speaker: Doctor J. Li (Beijing, CN)

Access
Abstract
Like
Thumbnail

Bleedings during antithrombotic therapy: a blessing in disguise

Speaker: Doctor D. Cosmi (Perugia, IT)

Access
Abstract
Slides
Like
Thumbnail

Efficacy and safety of oral anticoagulant versus antiplatelet therapy for secondary prevention of cardiovascular disease in patients without atrial fibrillation

Speaker: Assistant Professor F. Ricci (Chieti, IT)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Antiplatelet therapy

Speakers: Doctor D. Errigo, Doctor I. Lianos, Doctor J. Li, Doctor D. Cosmi, Assistant Professor F. Ricci
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources